|
業務類別
|
Biotechnology |
|
業務概覽
|
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006). |
| 公司地址
| 901 Gateway Boulevard, Third Floor, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 900-4520 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.corvuspharma.com |
| 員工數量
| 31 |
| Mr. Leiv Lea |
Chief Financial Officer and Principal Accounting Officer |
美元 394.66K |
25/04/2025 |
| Dr. Richard A. Miller,M.D. |
President, Chief Executive Officer and Chairman of the Board |
美元 32.68K |
25/04/2025 |
| Mr. Jeffrey Arcara |
Senior Vice President and Chief Business Officer |
-- |
25/04/2025 |
| Mr. William Benton Jones |
Senior Vice President, Pharmaceutical Development |
美元 350.10K |
25/04/2025 |
|
|
| Mr. Richard A. van den Broek |
Director |
09/04/2025 |
| Mr. Ian T. Clark |
Independent Director |
25/04/2025 |
| Dr. Peter A. Thompson,M.D.,F.A.C.P. |
Independent Director |
25/04/2025 |
| Dr. Linda S. Grais, J.D.,M.D. |
Independent Director |
25/04/2025 |
| Dr. Richard A. Miller,M.D. |
President, Chief Executive Officer and Chairman of the Board |
25/04/2025 |
| Mr. David Moore |
Director |
02/10/2025 |
| Mr. Scott William Morrison |
Independent Director |
25/04/2025 |
|
|
|
|
